No delayed restenosis at 18 months after implantation of sirolimus‐eluting stent
- 13 August 2002
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 57 (1) , 65-68
- https://doi.org/10.1002/ccd.10266
Abstract
Sirolimus‐eluting stent is emerging as a potential solution for the prevention of restenosis. Recently, a sustained suppression of neointimal proliferation 12 months after implantation of this stent was reported. This is the first report of angiographic and IVUS images 18 months after the implantation of a sirolimus‐eluting stent. Cathet Cardiovasc Intervent 2002;57:65–68.Keywords
This publication has 9 references indexed in Scilit:
- Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting StentsCirculation, 2001
- Radioactive Stents Delay but Do Not Prevent In-Stent Neointimal HyperplasiaCirculation, 2001
- Edge Restenosis After Implantation of High Activity 32 P Radioactive β-Emitting StentsCirculation, 2000
- Late Coronary Occlusion After Intracoronary BrachytherapyCirculation, 1999
- Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell CycleCirculation, 1999
- Electrocardiogram-Gated Intravascular Ultrasound Image Acquisition After Coronary Stent Deployment Facilitates On-Line Three-Dimensional Reconstruction and Automated Lumen QuantificationJournal of the American College of Cardiology, 1997
- Rapamycin inhibits vascular smooth muscle cell migration.Journal of Clinical Investigation, 1996
- Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle CellsCirculation Research, 1995
- Validation of quantitative analysis of intravascular ultrasound imagesThe International Journal of Cardiovascular Imaging, 1991